Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus vs cyclophosphamide for induction therapy in lupus nephritis
CTR20140883Phase 3Completed
- Sponsor
- Astellas Pharma
- Start
- Dec 2014
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tacrolimus in lupus nephritis (LN), systemic lupus erythematosus (SLE), sponsored by Astellas Pharma. Started Dec 2014; status: completed.
02
Drugs
tacrolimus
03
Conditions
lupus nephritis (LN)systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on CTR20140883.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140883.